Viracta Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Viracta Therapeutics, Inc.‘s stocks are currently a part of 27 hedge funds’ portfolios, which represents 8.55% of the total amount of its stocks outstanding. This makes up a total of 3.23M shares of Viracta Therapeutics, Inc.. Compared to the previous quarter, the number fell by -73.88% or -9.13M shares fewer. As for the holding position changes, 14.81% (4) of current hedge fund investors increased the number of shares held, 25.93% (7) of current holders sold a part of the shares held, and 29.63% (8) closed the holdings completely. 2 hedge funds are new holders of Viracta Therapeutics, Inc. stock in Q1 2023, it is 7.41% of total holders.
Hedge funds holding Viracta Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 0 |
|---|---|
| Q3 2018 | 0 |
| Q4 2018 | 0 |
| Q1 2019 | 0 |
| Q2 2019 | 0 |
| Q3 2019 | 0 |
| Q4 2019 | 0 |
| Q1 2020 | 0 |
| Q2 2020 | 0 |
| Q3 2020 | 0 |
| Q4 2020 | 0 |
| Q1 2021 | 42 |
| Q2 2021 | 56 |
| Q3 2021 | 62 |
| Q4 2021 | 63 |
| Q1 2022 | 63 |
| Q2 2022 | 56 |
| Q3 2022 | 53 |
| Q4 2022 | 53 |
| Q1 2023 | 27 |
Hedge funds changes in Viracta Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 0 | 0 | 0 | 0 | 0 |
| Q4 2018 | 0 | 0 | 0 | 0 | 0 |
| Q1 2019 | 0 | 0 | 0 | 0 | 0 |
| Q2 2019 | 0 | 0 | 0 | 0 | 0 |
| Q3 2019 | 0 | 0 | 0 | 0 | 0 |
| Q4 2019 | 0 | 0 | 0 | 0 | 0 |
| Q1 2020 | 0 | 0 | 0 | 0 | 0 |
| Q2 2020 | 0 | 0 | 0 | 0 | 0 |
| Q3 2020 | 0 | 0 | 0 | 0 | 0 |
| Q4 2020 | 0 | 0 | 0 | 0 | 0 |
| Q1 2021 | 42 | 0 | 0 | 0 | 0 |
| Q2 2021 | 27 | 11 | 11 | 13 | -6 |
| Q3 2021 | 15 | 18 | 15 | 8 | 6 |
| Q4 2021 | 13 | 15 | 20 | 12 | 3 |
| Q1 2022 | 13 | 12 | 22 | 12 | 4 |
| Q2 2022 | 12 | 8 | 23 | 17 | -4 |
| Q3 2022 | 5 | 15 | 15 | 9 | 9 |
| Q4 2022 | 11 | 13 | 13 | 10 | 6 |
| Q1 2023 | 2 | 4 | 7 | 8 | 6 |
Hedge funds changes in Viracta Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 537,000 | 41,000 |
|---|---|---|
| Q3 2018 | 214,000 | 134,000 |
| Q4 2018 | 48,000 | 5,000 |
| Q1 2019 | 19,000 | 27,000 |
| Q2 2019 | 36,000 | 5,000 |
| Q3 2019 | 35,000 | 2,000 |
| Q4 2019 | 11,000 | 1,000 |
| Q1 2020 | 38,000 | 2,000 |
| Q2 2020 | 14,000 | 0 |
| Q3 2020 | 258,000 | 0 |
| Q4 2020 | 193,000 | 0 |
| Q1 2021 | 925,000 | 800,000 |
| Q2 2021 | 885,000 | 961,000 |
| Q3 2021 | 497,000 | 673,000 |
| Q4 2021 | 143,000 | 341,000 |
| Q1 2022 | 934,000 | 287,000 |
| Q2 2022 | 716,000 | 226,000 |
| Q3 2022 | 627,000 | 235,000 |
| Q4 2022 | 64,962 | 6,424 |
| Q1 2023 | 959,000 | 318,000 |